Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

CRISPR in context: towards a socially responsible debate on embryo editing

Open access
Morrison, Michael, de Saille, Stevienna · 2019 · Palgrave Communications

Abstract

Following the birth in 2018 of two babies from embryos altered using CRISPR-Cas9, human germline gene editing (GGE) moved from abstract concern to reality. He Jiankui, the scientist responsible, has been roundly condemned by most scientific, legal and ethical commentators. However, opinions remain divided on whether GGE could be acceptably used in the future, and how, or if it should be prohibited entirely. The many reviews, summits, positions statements and high-level meetings that have accompanied the emergence of CRISPR technology acknowledge this, calling for greater public engagement to help reach a consensus on how to proceed. These calls are laudable but far from unproblematic. Consensus is not only hugely challenging to reach, but difficult to measure and to know when it might be achieved. Engagement is clearly desirable, but engagement strategies need to avoid the limitations of previous encounters between publics and biotechnology. Here we set CRISPR in the context of the biotechnology and fertility industries to illustrate the lessons to be learned. In particular we demonstrate the importance of avoiding a ‘deficit mode’ in which resistance is attributed to a lack of public understanding of science, addressing the separation of technical safety criteria from ethical and social matters, and ensuring the scope of the debate includes the political-economic context in which science is conducted and new products and services are brought to market. Through this history, we draw on Mary Douglas’ classic anthropological notion of ‘matter out of place’ to explain why biotechnologies evoke feelings of unease and anxiety, and recommend this as a model for rehabilitating lay apprehension about novel biological technologies as legitimate matters of concern in future engagement exercises about GGE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1057/s41599-019-0319-5

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 64 references

Research works printed but not linked: 6

  1. Kannegiesser H (1988) Conception in the test tube: the IVF story, How Australia Leads the World. Macmillan, South Melbourne
  2. National Academy Of Sciences; National Academy Of Medicine (2017) Human Genome Editing: Science, Ethics and Governance. The National Acadamies Press, Washington, DC
  3. Regalado A (2018c) Rogue Chinese CRISPR scientist cited US report as his green light. MIT Technology Review. Rogue Chinese CRISPR scientist cited US report as his green light. Accessed 15 Aug 2019
  4. Skloot R (2011) The immortal life of Henrietta Lacks. Broadway Books, New York
  5. United States President’s Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research (1982) Splicing life: a report on the social and ethical issues of genetic engineering with human beings. The Commission, Washington, DC
  6. Wipperman A, Campos M (2016) Genome editing technologies: the patient perspective. Genetic Alliance UK, London

Cited by

See all 62

Metadata

Authors
Morrison, M., & de Saille, S.
Affiliations
University of Oxford (GB)
Corresponding author
Morrison, Michael
Venue
Palgrave Communications
Published
2019-09-24
Volume
5
Issue
1
ISSN
2055-1045 (ISSN-L)
OpenAlex
W2975522953
Cited by
62
References
64
Citations by year
2026: 2 · 2025: 8 · 2024: 14 · 2023: 18 · 2022: 6 · 2021: 10 · 2020: 4
FWCI
3.44
Type
journal article
Language
en
Open access
Licence
Locations
  • Humanities and Social Sciences Communications (publishedVersion, cc-by)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Economic and Social Research Council (ES/P002943/1)
Topics
  • Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
  • Social Sciences › Arts and Humanities › History and Philosophy of Science › Bioethics and Human Rights Issues
Keywords
CRISPR/Cas9, germline editing, embryo editing, public engagement with science, deficit model, Mary Douglas, ethics of biotechnology, fertility industry, biotechnology regulation, He Jiankui, social responsibility, political economy of science

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CRISPR in context: towards a socially responsible debate on embryo editing. https://app.cochat.ai/papers/10.1057/s41599-019-0319-5
The paper
Morrison, M., & de Saille, S. (2019). CRISPR in context: towards a socially responsible debate on embryo editing. Palgrave Communications. https://doi.org/10.1057/s41599-019-0319-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.